Pharming Group
ISIN NL0010391025
|WKN A1H65A
Overview
Description
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Netherlands
Financials
Key metrics
| Market capitalisation, EUR | 591.22 m |
| EPS, EUR | -0.01 |
| P/B ratio | 2.99 |
| P/E ratio | 58.61 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 226.91 m |
| Net income, EUR | -9.76 m |
| Profit margin | -4.30% |
What ETF is Pharming Group in?
There are 16 ETFs which contain Pharming Group. All of these ETFs are listed in the table below. The ETF with the largest weighting of Pharming Group is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| Xtrackers MSCI Europe Small Cap UCITS ETF 1C | 0.06% | Equity Europe Small Cap | 897 | 0.30% | 1,352 | +9.11% | DBX1AU | LU0322253906 |
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,417 | 0.45% | 750 | +16.21% | A1W56P | IE00BCBJG560 |
| UBS ETF (LU) MSCI EMU Small Cap UCITS ETF (EUR) A-dis | 0.14% | Equity Europe Small Cap | 418 | 0.33% | 189 | +9.45% | A1JHNE | LU0671493277 |
| UBS ETF (LU) MSCI EMU Select Factor Mix UCITS ETF (EUR) A-acc | 0.03% | Equity Europe Multi-Factor Strategy | 575 | 0.34% | 12 | +14.52% | A2JKF5 | LU1804202403 |
| iShares Healthcare Innovation UCITS ETF | 0.12% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 981 | +0.60% | A2ANH2 | IE00BYZK4776 |
| Xtrackers MSCI Global SDGs UCITS ETF 1C | 0.03% | Equity World Social/Environmental | 279 | 0.35% | 13 | -3.32% | DBX0SL | IE000PSF3A70 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.48% | Equity World Social/Environmental Innovation | 361 | 0.60% | 4 | +6.08% | A3DHPA | IE000VTOHNZ0 |
| SPDR MSCI Europe Small Cap UCITS ETF | 0.06% | Equity Europe Small Cap | 906 | 0.30% | 216 | +7.24% | A1191W | IE00BKWQ0M75 |
| iShares MSCI EMU Small Cap UCITS ETF (Acc) | 0.15% | Equity Europe Small Cap | 408 | 0.58% | 761 | +9.19% | A0X8SE | IE00B3VWMM18 |
| Amundi MSCI Europe Small Cap ESG Climate Net Zero Ambition CTB UCITS ETF Acc | 0.03% | Equity Europe Small Cap Climate Change | 873 | 0.23% | 20 | - | A2H566 | LU1681041544 |
| iShares MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,376 | 0.35% | 3,499 | +15.71% | A2DWBY | IE00BF4RFH31 |
| Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 0.04% | Equity World Health Care Social/Environmental | 115 | 0.35% | 138 | +7.73% | DBX0SM | IE00036F4K40 |
| SPDR MSCI Europe Small Cap Value Weighted UCITS ETF | 0.02% | Equity Europe Small Cap | 874 | 0.30% | 178 | +10.59% | A12HU7 | IE00BSPLC298 |
| L&G Pharma Breakthrough UCITS ETF | 3.03% | Equity World Health Care Innovation | 32 | 0.49% | 17 | -16.70% | A2H9XR | IE00BF0H7608 |
| Amundi MSCI Europe Small Cap ESG Climate Net Zero Ambition CTB UCITS ETF Dist | 0.03% | Equity Europe Small Cap Climate Change | 873 | 0.35% | 88 | +8.20% | ETF045 | LU2572257470 |
| Amundi MSCI EMU Small Cap ESG CTB Net Zero Ambition UCITS ETF | 0.11% | Equity Europe Small Cap | 392 | 0.40% | 312 | +8.54% | LYX0W3 | LU1598689153 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.